Time to address bleeding and clotting in cancer.
作者信息
Li Ang
机构信息
Baylor College of Medicine.
出版信息
Blood. 2024 Nov 28;144(22):2280-2281. doi: 10.1182/blood.2024026522.
Abstract
摘要
相似文献
1
Time to address bleeding and clotting in cancer.是时候解决癌症中的出血和凝血问题了。
Blood. 2024 Nov 28;144(22):2280-2281. doi: 10.1182/blood.2024026522.
2
Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B.凝血因子浓缩物用于预防甲型或乙型血友病患者的出血及与出血相关的并发症。
Cochrane Database Syst Rev. 2005 Apr 18(2):CD003429. doi: 10.1002/14651858.CD003429.pub2.
3
Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B.凝血因子浓缩物用于预防甲型或乙型血友病患者的出血及与出血相关的并发症。
Cochrane Database Syst Rev. 2006 Apr 19(2):CD003429. doi: 10.1002/14651858.CD003429.pub3.
4
Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B.凝血因子浓缩物用于预防甲型或乙型血友病患者的出血及与出血相关的并发症。
Cochrane Database Syst Rev. 2011 Sep 7(9):CD003429. doi: 10.1002/14651858.CD003429.pub4.
5
Clotting factor concentrates for preventing bleeding and bleeding-related complications in previously treated individuals with haemophilia A or B.用于预防既往接受过治疗的 A 型或 B 型血友病患者出血和出血相关并发症的凝血因子浓缩物。
Cochrane Database Syst Rev. 2021 Aug 18;8(8):CD014201. doi: 10.1002/14651858.CD014201.
6
Clotting Factor Concentration During Menstrual Phases in Women With and Without Heavy Menstrual Bleeding: A Systematic Review and Meta-Analysis.有和无月经过多的女性月经周期各阶段的凝血因子浓度：一项系统评价和荟萃分析
Haemophilia. 2025 Jul;31(4):780-786. doi: 10.1111/hae.70076. Epub 2025 Jun 19.
7
Prothrombin complex concentrate in cardiac surgery for the treatment of coagulopathic bleeding.心脏手术中使用凝血酶原复合物浓缩物治疗凝血功能障碍性出血。
Cochrane Database Syst Rev. 2022 Nov 21;11(11):CD013551. doi: 10.1002/14651858.CD013551.pub2.
8
Drugs to reduce bleeding and transfusion in major open vascular or endovascular surgery: a systematic review and network meta-analysis.减少大型开放性血管或血管内手术中出血和输血的药物：系统评价和网络荟萃分析。
Cochrane Database Syst Rev. 2023 Feb 17;2(2):CD013649. doi: 10.1002/14651858.CD013649.pub2.
9
Unveiling the potency of ready-to-use brodifacoum blocks in lesser bandicoot rats: exploring toxicity, blood clotting factors, and organ histology.揭示即用型溴敌隆块对小袋狸鼠的毒性：探索毒性、凝血因子和器官组织学
Toxicol Res (Camb). 2024 Aug 1;13(4):tfae116. doi: 10.1093/toxres/tfae116. eCollection 2024 Aug.
10
Standard- versus extended-duration anticoagulation for primary venous thromboembolism prophylaxis in acutely ill medical patients.急性病内科患者原发性静脉血栓栓塞症预防中标准疗程与延长疗程抗凝治疗的比较
Cochrane Database Syst Rev. 2024 Dec 4;12(12):CD014541. doi: 10.1002/14651858.CD014541.pub2.
本文引用的文献
1
Bleeding events in patients with cancer: incidence, risk factors, and impact on prognosis in a prospective cohort study.癌症患者的出血事件：一项前瞻性队列研究中的发生率、风险因素和对预后的影响。
Blood. 2024 Nov 28;144(22):2349-2359. doi: 10.1182/blood.2024025362.
2
Venous thromboembolism prevention in cancer care: implementation strategies to address underuse.癌症护理中的静脉血栓栓塞预防：解决使用不足问题的实施策略。
Res Pract Thromb Haemost. 2023 Aug 20;7(7):102173. doi: 10.1016/j.rpth.2023.102173. eCollection 2023 Oct.
3
Derivation and Validation of a Clinical Risk Assessment Model for Cancer-Associated Thrombosis in Two Unique US Health Care Systems.在两个独特的美国医疗保健系统中，癌症相关血栓形成的临床风险评估模型的推导和验证。
J Clin Oncol. 2023 Jun 1;41(16):2926-2938. doi: 10.1200/JCO.22.01542. Epub 2023 Jan 10.
4
Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.门诊癌症患者化疗时的静脉血栓栓塞症的一级预防。
Cochrane Database Syst Rev. 2020 Dec 18;12(12):CD008500. doi: 10.1002/14651858.CD008500.pub5.
5
A Meta-Analysis of Case Fatality Rates of Recurrent Venous Thromboembolism and Major Bleeding in Patients with Cancer.癌症患者复发性静脉血栓栓塞和大出血的病死率的荟萃分析。
Thromb Haemost. 2020 Apr;120(4):702-713. doi: 10.1055/s-0040-1708481. Epub 2020 Apr 14.
6
A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts.一种癌症相关静脉血栓栓塞的临床预测模型：在两个独立前瞻性队列中的开发与验证研究
Lancet Haematol. 2018 Jul;5(7):e289-e298. doi: 10.1016/S2352-3026(18)30063-2. Epub 2018 Jun 7.
7
Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH.非手术患者心房颤动和静脉血栓栓塞性疾病抗凝剂研究中临床相关非大出血的定义：国际血栓与止血学会科学与标准化委员会的沟通
J Thromb Haemost. 2015 Nov;13(11):2119-26. doi: 10.1111/jth.13140.
8
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients.在外科患者抗血栓药物临床研究中主要出血的定义。
J Thromb Haemost. 2010 Jan;8(1):202-4. doi: 10.1111/j.1538-7836.2009.03678.x. Epub 2009 Oct 30.
9
Development and validation of a predictive model for chemotherapy-associated thrombosis.化疗相关性血栓形成预测模型的开发与验证
Blood. 2008 May 15;111(10):4902-7. doi: 10.1182/blood-2007-10-116327. Epub 2008 Jan 23.
Zotero 插件